Correlation Between Bristol-Myers Squibb and Mundus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and Mundus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and Mundus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Mundus Group, you can compare the effects of market volatilities on Bristol-Myers Squibb and Mundus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of Mundus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and Mundus.

Diversification Opportunities for Bristol-Myers Squibb and Mundus

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Bristol-Myers and Mundus is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Mundus Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mundus Group and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Mundus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mundus Group has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and Mundus go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and Mundus

Assuming the 90 days horizon Bristol Myers Squibb is expected to generate 0.27 times more return on investment than Mundus. However, Bristol Myers Squibb is 3.68 times less risky than Mundus. It trades about 0.07 of its potential returns per unit of risk. Mundus Group is currently generating about -0.01 per unit of risk. If you would invest  84,453  in Bristol Myers Squibb on October 26, 2024 and sell it today you would earn a total of  9,069  from holding Bristol Myers Squibb or generate 10.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy96.83%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Mundus Group

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol-Myers Squibb reported solid returns over the last few months and may actually be approaching a breakup point.
Mundus Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mundus Group has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest fragile performance, the Stock's fundamental indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Bristol-Myers Squibb and Mundus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and Mundus

The main advantage of trading using opposite Bristol-Myers Squibb and Mundus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, Mundus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mundus will offset losses from the drop in Mundus' long position.
The idea behind Bristol Myers Squibb and Mundus Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Directory
Find actively traded commodities issued by global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance